Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study.
Sesmilo G, Resmini E, Bernabeu I, Aller J, Soto A, Mora M, Picó A, Fajardo C, Torres E, Alvarez-Escolá C, García R, Blanco C, Cámara R, Gaztambide S, Salinas I, Pozo CD, Castells I, Villabona C, Biagetti B, Webb SM. Sesmilo G, et al. Among authors: aller j. Clin Endocrinol (Oxf). 2014 Dec;81(6):883-90. doi: 10.1111/cen.12440. Epub 2014 Mar 19. Clin Endocrinol (Oxf). 2014. PMID: 24612232
[Neuroendocrinology in 2011].
Puig Domingo M, Castaño J, Alvarez-Escolá C, Resmini E, Venegas E, García Arnés J, Torres E, Lecumberri B, Barahona MJ, Lamas C, Fajardo C, Cámara R, Vicente A, Blanco C, Villabona C, Del Pozo C, Halperin I, Salinas I, Sesmilo G, Aller J, Marazuela M, Webb SM, Bernabeu I. Puig Domingo M, et al. Among authors: aller j. Endocrinol Nutr. 2012 May;59(5):311-25. doi: 10.1016/j.endonu.2012.01.009. Epub 2012 Mar 16. Endocrinol Nutr. 2012. PMID: 22425316 Spanish. No abstract available.
Long-term treatment with pegvisomant for acromegaly: a 10-year experience.
Ramos-Leví AM, Bernabeu I, Álvarez-Escolá C, Aller J, Lucas T, de Miguel P, Rodríguez-Cañete L, Sampedro-Núñez MA, Halperin I, Puig-Domingo M, Marazuela M. Ramos-Leví AM, et al. Among authors: aller j. Clin Endocrinol (Oxf). 2016 Apr;84(4):540-50. doi: 10.1111/cen.12993. Epub 2016 Jan 26. Clin Endocrinol (Oxf). 2016. PMID: 26662620
Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus.
Bernabeu I, Aller J, Álvarez-Escolá C, Fajardo-Montañana C, Gálvez-Moreno Á, Guillín-Amarelle C, Sesmilo G. Bernabeu I, et al. Among authors: aller j. Endocrinol Diabetes Nutr (Engl Ed). 2018 May;65(5):297-305. doi: 10.1016/j.endinu.2018.01.008. Epub 2018 Apr 10. Endocrinol Diabetes Nutr (Engl Ed). 2018. PMID: 29653911 English, Spanish.
A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly.
Trainer PJ, Newell-Price JDC, Ayuk J, Aylwin SJB, Rees A, Drake W, Chanson P, Brue T, Webb SM, Fajardo C, Aller J, McCormack AI, Torpy DJ, Tachas G, Atley L, Ryder D, Bidlingmaier M. Trainer PJ, et al. Among authors: aller j. Eur J Endocrinol. 2018 Aug;179(2):97-108. doi: 10.1530/EJE-18-0138. Epub 2018 May 22. Eur J Endocrinol. 2018. PMID: 29789410 Free PMC article. Clinical Trial.
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis.
Cordero-Barreal A, Caleiras E, López de Maturana E, Monteagudo M, Martínez-Montes ÁM, Letón R, Gil E, Álvarez-Escolá C, Regojo RM, Andía V, Marazuela M, Guadalix S, Calatayud M, Robles-Díaz L, Aguirre M, Cano JM, Díaz JÁ, Saavedra P, Lamas C, Azriel S, Sastre J, Aller J, Leandro-García LJ, Calsina B, Roldán-Romero JM, Santos M, Lanillos J, Cascón A, Rodríguez-Antona C, Robledo M, Montero-Conde C. Cordero-Barreal A, et al. Among authors: aller j. J Clin Endocrinol Metab. 2020 Nov 1;105(11):dgaa527. doi: 10.1210/clinem/dgaa527. J Clin Endocrinol Metab. 2020. PMID: 32791518
92 results